USD 0.25
(-9.42%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 19.84 Million USD | -22.95% |
2022 | 25.75 Million USD | -72.51% |
2021 | 93.68 Million USD | -35.26% |
2020 | 144.7 Million USD | 506.59% |
2019 | 23.85 Million USD | 277.27% |
2018 | 6.32 Million USD | -4.25% |
2017 | 6.6 Million USD | 112.76% |
2016 | 3.1 Million USD | 7.78% |
2015 | 2.88 Million USD | 22.45% |
2014 | 2.35 Million USD | -10.33% |
2013 | 2.62 Million USD | -46.84% |
2012 | 4.93 Million USD | 37.82% |
2011 | 3.58 Million USD | -54.93% |
2010 | 7.94 Million USD | -58.42% |
2009 | 19.1 Million USD | -40.05% |
2008 | 31.86 Million USD | -54.89% |
2007 | 70.64 Million USD | 35.32% |
2006 | 52.2 Million USD | -4.14% |
2005 | 54.46 Million USD | 60.36% |
2004 | 33.96 Million USD | 50.41% |
2003 | 22.58 Million USD | 4836.38% |
2002 | 457.42 Thousand USD | 194.75% |
2001 | 155.19 Thousand USD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 25.27 Million USD | -5.42% |
2024 Q1 | 26.72 Million USD | 34.65% |
2023 Q3 | 20.76 Million USD | -8.15% |
2023 Q2 | 22.61 Million USD | -9.0% |
2023 Q1 | 24.84 Million USD | -3.54% |
2023 FY | 19.84 Million USD | -22.95% |
2023 Q4 | 19.84 Million USD | -4.44% |
2022 Q4 | 25.75 Million USD | -15.99% |
2022 Q3 | 30.65 Million USD | -12.26% |
2022 Q2 | 34.94 Million USD | -41.45% |
2022 Q1 | 59.68 Million USD | -36.29% |
2022 FY | 25.75 Million USD | -72.51% |
2021 Q3 | 115.82 Million USD | -13.16% |
2021 Q2 | 133.37 Million USD | -7.97% |
2021 Q1 | 144.92 Million USD | 0.16% |
2021 FY | 93.68 Million USD | -35.26% |
2021 Q4 | 93.68 Million USD | -19.11% |
2020 Q4 | 144.7 Million USD | 73.79% |
2020 FY | 144.7 Million USD | 506.59% |
2020 Q1 | 22.88 Million USD | -4.06% |
2020 Q2 | 25.04 Million USD | 9.44% |
2020 Q3 | 83.26 Million USD | 232.43% |
2019 Q1 | 7.21 Million USD | 14.14% |
2019 Q4 | 23.85 Million USD | -2.43% |
2019 Q3 | 24.45 Million USD | 52.24% |
2019 FY | 23.85 Million USD | 277.27% |
2019 Q2 | 16.06 Million USD | 122.53% |
2018 FY | 6.32 Million USD | -4.25% |
2018 Q1 | 3.78 Million USD | -42.73% |
2018 Q2 | 7.89 Million USD | 108.78% |
2018 Q3 | 8.47 Million USD | 7.38% |
2018 Q4 | 6.32 Million USD | -25.43% |
2017 Q2 | 11.21 Million USD | 281.36% |
2017 FY | 6.6 Million USD | 112.76% |
2017 Q1 | 2.94 Million USD | -5.28% |
2017 Q4 | 6.6 Million USD | -25.51% |
2017 Q3 | 8.86 Million USD | -20.92% |
2016 Q3 | 3.85 Million USD | 86.23% |
2016 Q2 | 2.06 Million USD | 0.1% |
2016 FY | 3.1 Million USD | 7.78% |
2016 Q1 | 2.06 Million USD | -28.23% |
2016 Q4 | 3.1 Million USD | -19.44% |
2015 FY | 2.88 Million USD | 22.45% |
2015 Q4 | 2.88 Million USD | 49.53% |
2015 Q3 | 1.92 Million USD | 0.63% |
2015 Q2 | 1.91 Million USD | 42.94% |
2015 Q1 | 1.33 Million USD | -43.07% |
2014 Q3 | 2.64 Million USD | 14.95% |
2014 Q4 | 2.35 Million USD | -11.08% |
2014 FY | 2.35 Million USD | -10.33% |
2014 Q1 | 2.09 Million USD | -20.24% |
2014 Q2 | 2.3 Million USD | 9.99% |
2013 Q3 | 2.08 Million USD | -38.0% |
2013 Q2 | 3.36 Million USD | 0.99% |
2013 Q1 | 3.33 Million USD | -32.45% |
2013 FY | 2.62 Million USD | -46.84% |
2013 Q4 | 2.62 Million USD | 25.68% |
2012 Q1 | 2.63 Million USD | -26.4% |
2012 FY | 4.93 Million USD | 37.82% |
2012 Q2 | 3.47 Million USD | 31.92% |
2012 Q3 | 3.67 Million USD | 5.61% |
2012 Q4 | 4.93 Million USD | 34.4% |
2011 Q1 | 6.25 Million USD | -21.21% |
2011 FY | 3.58 Million USD | -54.93% |
2011 Q2 | 3.48 Million USD | -44.38% |
2011 Q3 | 3.04 Million USD | -12.55% |
2011 Q4 | 3.58 Million USD | 17.61% |
2010 Q3 | 3.48 Million USD | -53.49% |
2010 Q2 | 7.48 Million USD | -52.92% |
2010 Q4 | 7.94 Million USD | 128.14% |
2010 FY | 7.94 Million USD | -58.42% |
2010 Q1 | 15.9 Million USD | -16.77% |
2009 Q2 | 18.22 Million USD | -16.16% |
2009 Q1 | 21.74 Million USD | -31.77% |
2009 Q4 | 19.1 Million USD | -8.3% |
2009 Q3 | 20.83 Million USD | 14.29% |
2009 FY | 19.1 Million USD | -40.05% |
2008 Q3 | 48.42 Million USD | -3.55% |
2008 Q4 | 31.86 Million USD | -34.2% |
2008 Q1 | 58.48 Million USD | -17.21% |
2008 FY | 31.86 Million USD | -54.89% |
2008 Q2 | 50.2 Million USD | -14.16% |
2007 Q1 | 64.59 Million USD | 23.72% |
2007 Q3 | 43.89 Million USD | -17.37% |
2007 Q2 | 53.12 Million USD | -17.75% |
2007 FY | 70.64 Million USD | 35.32% |
2007 Q4 | 70.64 Million USD | 60.94% |
2006 Q3 | 34.36 Million USD | -17.15% |
2006 Q1 | 47.19 Million USD | -13.35% |
2006 Q4 | 52.2 Million USD | 51.91% |
2006 Q2 | 41.48 Million USD | -12.11% |
2006 FY | 52.2 Million USD | -4.14% |
2005 Q3 | 21.61 Million USD | -19.76% |
2005 Q4 | 54.46 Million USD | 152.02% |
2005 Q1 | 30.54 Million USD | -10.06% |
2005 FY | 54.46 Million USD | 60.36% |
2005 Q2 | 26.93 Million USD | -11.83% |
2004 Q1 | 20.13 Million USD | -10.83% |
2004 FY | 33.96 Million USD | 50.41% |
2004 Q4 | 33.96 Million USD | 123.94% |
2004 Q3 | 15.16 Million USD | -10.76% |
2004 Q2 | 16.99 Million USD | -15.6% |
2003 Q3 | 23.84 Million USD | 0.0% |
2003 Q4 | 22.58 Million USD | -5.32% |
2003 FY | 22.58 Million USD | 4836.38% |
2003 Q1 | 296.88 Thousand USD | -35.1% |
2002 Q4 | 457.42 Thousand USD | 0.0% |
2002 FY | 457.42 Thousand USD | 194.75% |
2002 Q1 | 156.37 Thousand USD | 0.0% |
2001 FY | 155.19 Thousand USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Inovalon Holdings, Inc. | 1.97 Billion USD | 98.993% |
GE HealthCare Technologies Inc. | 32.45 Billion USD | 99.939% |
Sharecare, Inc. | 613.63 Million USD | 96.766% |
Progyny, Inc. | 756.62 Million USD | 97.377% |
Aclarion, Inc. | 2.45 Million USD | -706.822% |
CareMax, Inc. | 623.3 Million USD | 96.816% |
Simulations Plus, Inc. | 196.63 Million USD | 89.907% |
CareCloud, Inc. | 79.51 Million USD | 75.041% |
Forian Inc. | 59.37 Million USD | 66.576% |
Bullfrog AI Holdings, Inc. Warrants | 2.77 Million USD | -614.763% |
Bullfrog AI Holdings, Inc. Common Stock | 2.77 Million USD | -614.763% |
Minerva Surgical, Inc. | 68.9 Million USD | 71.196% |
Omnicell, Inc. | 2.22 Billion USD | 99.109% |
Definitive Healthcare Corp. | 1.82 Billion USD | 98.913% |
Zhongchao Inc. | 24.41 Million USD | 18.719% |
Accolade, Inc. | 788.15 Million USD | 97.482% |
Streamline Health Solutions, Inc. | 41.74 Million USD | 52.453% |
SOPHiA GENETICS SA | 206.15 Million USD | 90.373% |
R1 RCM Inc. | 4.96 Billion USD | 99.6% |
Spok Holdings, Inc. | 227.68 Million USD | 91.284% |
Privia Health Group, Inc. | 999.9 Million USD | 98.015% |
EUDA Health Holdings Limited | 1.31 Million USD | -1414.375% |
HeartBeam, Inc. | 17.13 Million USD | -15.848% |
GeneDx Holdings Corp. | 473.67 Million USD | 95.81% |
TruBridge, Inc. | 434.42 Million USD | 95.432% |
Nutex Health, Inc. | 398.24 Million USD | 95.017% |
Renalytix Plc | 7.97 Million USD | -148.946% |
Sharecare, Inc. | 613.63 Million USD | 96.766% |
Health Catalyst, Inc. | 701.81 Million USD | 97.172% |
10x Genomics, Inc. | 965.14 Million USD | 97.944% |
GoodRx Holdings, Inc. | 1.58 Billion USD | 98.751% |
SCWorx Corp. | 6.27 Million USD | -216.109% |
Schrödinger, Inc. | 802.95 Million USD | 97.528% |
HealthEquity, Inc. | 3.23 Billion USD | 99.387% |
HealthStream, Inc. | 499.94 Million USD | 96.03% |
MSP Recovery, Inc. | 3.15 Billion USD | 99.372% |
Augmedix, Inc. | 66.71 Million USD | 70.251% |
BrightSpring Health Services, Inc. Common Stock | 5.79 Billion USD | 99.657% |
Ontrak, Inc. | 19.84 Million USD | 0.0% |
SHL Telemedicine Ltd. | 113.04 Million USD | 82.445% |
CareCloud, Inc. | 79.51 Million USD | 75.041% |
Premier, Inc. | 3.42 Billion USD | 99.421% |
Certara, Inc. | 1.56 Billion USD | 98.73% |
GeneDx Holdings Corp. | 473.67 Million USD | 95.81% |
OneMedNet Corporation | 463.05 Thousand USD | -4185.865% |
BrightSpring Health Services, Inc. Tangible Equity Unit | 5.79 Billion USD | 99.657% |
EUDA Health Holdings Limited | 1.31 Million USD | -1414.375% |
HeartBeam, Inc. | 17.13 Million USD | -15.848% |
CareCloud, Inc. | 79.51 Million USD | 75.041% |
Mangoceuticals, Inc. | 1.05 Million USD | -1788.669% |
CareMax, Inc. | 623.3 Million USD | 96.816% |
Healthcare Triangle, Inc. | 10.04 Million USD | -97.492% |
National Research Corporation | 122.43 Million USD | 83.791% |
Aclarion, Inc. | 2.45 Million USD | -706.822% |
OptimizeRx Corporation | 183.37 Million USD | 89.177% |